Duramed Research clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Dec 23, 2008 · source ↗
The registry lists 24 studies whose lead sponsor is Duramed Research. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 16, 2023.
- 24studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- 23
- First submitted after Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Duramed Research’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Levonorgestrel2 in phase 30 open · 4
- Ethinyl Estradiol1 in phase 30 open · 3
- 0 open · 1
All 24 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed2396%
- Stopped early14%
Over the years
- 07
- 408
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 17 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
- Duramed Research24 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. All Teva Pharmaceutical Industries, Ltd. studies →
- A Safety Extension Study of DR-OXY-301CompletedNCT00782769Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001CompletedNCT00382408Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine HeadachesCompletedNCT00781456Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral ContraceptiveCompletedNCT00196326Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCompletedNCT00196313Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsCompletedNCT00196339Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive BladderCompletedNCT00685113Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal AtrophyCompletedNCT00361569Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent FemalesCompletedNCT00924560Phase 2
Sponsor listed in the registry: Duramed Research · First submitted after Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Trial to Evaluate DR-2021 in Women With Secondary AmenorrheaCompletedNCT00196391Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCompletedNCT00196365Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase ReplacementCompletedNCT00117468Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive RegimensCompletedNCT00117273Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic PainCompletedNCT00117481Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.CompletedNCT00196352Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro FertilizationCompletedNCT00615251Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal AtrophyCompletedNCT00196378Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral ContraceptiveCompletedNCT00362479Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityWithdrawnNCT00117260Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to SeasonaleCompletedNCT00394771Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal WomenCompletedNCT00592839Phase 4
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Emergency Contraception Actual Use StudyCompletedNCT00777556Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderCompletedNCT00196404Phase 2
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.
- A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot FlashesCompletedNCT00272935Phase 3
Sponsor listed in the registry: Duramed Research · First submitted before Duramed Research became part of Teva Pharmaceutical Industries, Ltd.